Desmoid tumor medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(24 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Desmoid tumor}}
{{Desmoid tumor}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}} {{AE}}{{S.M.}}{{Faizan}}
==Overview==
==Overview==
Medical therapy for desmoid tumor includes [[antiestrogen]]s (ex. [[tamoxifen]]), [[non-steroidal anti-inflammatory drug|NSAIDs]], [[chemotherapy]] or microwave ablation.
Wait and watch [[Strategy (NLP)|strategy]] is applied to [[Desmoid tumor|desmoid tumors]] which are [[asymptomatic]], unresectable, non-life threatening, not causing any significant [[impairment]], and resectable [[tumors]] with increased [[morbidity]] associated with [[surgery]].Different [[drugs]] including [[chemotherapeutic agents]], [[Non-steroidal anti-inflammatory drug|NSAIDs]], anti-hormonal agents and [[tyrosine kinase inhibitors]] can be used to shrink or [[Stabilizer (chemistry)|stabilize]] the [[tumor]] size and to improve the [[symptoms]]. [[Radiation therapy]] and [[tumor]] [[ablation]] with [[heat]], [[cold]], [[microwave]] and/or high-frequency [[Ultrasound|ultrasound waves]] can also be of [[therapeutic]] use as required.


==Medical Therapy==
==Medical Therapy==
Medical therapy for prolactinoma includes:<ref name="pmid22359346">{{cite journal |author=Wilkinson MJ, Fitzgerald JE, Thomas JM, Hayes AJ, Strauss DC|title=Surgical resection for non-familial adenomatous polyposis-related intra-abdominal fibromatosis |journal=BJS. |volume=99 |issue=5 |pages=706–13|year=2012 |doi=10.1002/bjs.8703 |pmid=22359346}}</ref><ref name="pmid22370045">{{cite journal| author=Rammohan A, Wood JJ| title=Desmoid tumour of the breast as a manifestation of Gardner's syndrome. | journal=Int J Surg Case Rep | year= 2012 | volume= 3 | issue= 5 | pages= 139-42 | pmid=22370045 | doi=10.1016/j.ijscr.2012.01.004 | pmc=PMC3312056 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22370045  }} </ref>
*Ideally, [[patients]] with [[Desmoid tumor|desmoid tumors]] should be evaluated by a multi-disciplinary team which includes [[surgeons]], [[medical]] [[oncologists]], [[Radiation Oncology|radiation]] [[oncologists]], [[geneticists]] and [[nurses]]
*[[Antiestrogen]]s (ex. [[Tamoxifen]])
*[[Patients]] with [[Desmoid tumor|desmoid tumors]] should be evaluated in a [[hospital]] with expertise in [[sarcoma]] (usually such [[hospitals]] are designated as [[National Comprehensive Cancer Network|NCCN [National Comprehensive Cancer Network] centers]])
*[[Non-steroidal anti-inflammatory drug|NSAIDs]]
*'''Wait and watch or observation''' of the [[tumor]] carefully with [[images]] and/or [[physical examination]], is implied as a primary [[therapeutic]] option for [[desmoid tumor]]<nowiki/>[[desmoid tumor|s]] with following [[Features (pattern recognition)|features]]:
*[[Chemotherapy]]
**Potentially resectable but [[asymptomatic]] or minimally [[symptomatic]]
*Microwave ablation
**Non-life threatening
Current experimental studies are being done with Gleevec ([[Imatinib]]) and Nexavar ([[sorafenib]]) for treatment of desmoid tumors, and show promising success rates.
**Not causing any [[Significant figure|significant]] [[impairment]]
**Stable [[appearance]] on [[Screening test|screening modalities]]
**Unresectable [[tumors]]
**Resectable but [[surgery]] would lead to unacceptable [[morbidity]]
**How often [[Scan|scans]] and/or [[Physical examination|physical exams]] are needed during a “wait and watch” period varies with each situation
*Treatment is recommended for extra-abdominal or [[abdominal]] [[Desmoid tumor|desmoid tumors]] associated with:
**[[Symptoms]]
**Progressively enlarging [[tumors]] irrespective of [[symptoms]]
**Imminent risk to adjacent structures
**[[Tumor]] creating cosmetic concerns
*'''Goals of medical therapy''' are:
**Shrinkage of [[tumor]] size
**[[Stabilization (medicine)|Stabilization]] of [[tumor]]
**Improvement in [[symptoms]] after a very wide variety of [[treatments]]
*Following table shows [[drugs]] used in [[Medical therapy template|medical therapy]] for [[Desmoid tumor|desmoid tumors]]:<ref name="pmid22359346">{{cite journal |author=Wilkinson MJ, Fitzgerald JE, Thomas JM, Hayes AJ, Strauss DC|title=Surgical resection for non-familial adenomatous polyposis-related intra-abdominal fibromatosis |journal=BJS. |volume=99 |issue=5 |pages=706–13|year=2012 |doi=10.1002/bjs.8703 |pmid=22359346}}</ref><ref name="pmid22370045">{{cite journal| author=Rammohan A, Wood JJ| title=Desmoid tumour of the breast as a manifestation of Gardner's syndrome. | journal=Int J Surg Case Rep | year= 2012 | volume= 3 | issue= 5 | pages= 139-42 | pmid=22370045 | doi=10.1016/j.ijscr.2012.01.004 | pmc=PMC3312056 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22370045  }} </ref>
{| class="wikitable"
|+Different drugs used in medical therapy of desmoid tumors
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Drug class
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Drug name
|-
|style="background:#DCDCDC;" align="center" + |'''Chemotherapeutic agents'''
|
* [[Doxorubicin]] ([[Adriamycin]], [[Doxorubicin hydrochloride|Rubex]])
* [[Doxorubicin liposome|Doxil (liposomal doxorubicin)]]
* [[Dacarbazine|Dacarbazine (DTIC-Dome)]]
* [[Methotrexate]]
* [[Vinorelbine]]
* [[Vinblastine]]
* [[Carboplatin]] ([[Paraplatin]])
|-
|style="background:#DCDCDC;" align="center" + |'''NSAIDs'''
|
* [[Sulindac]]
|-
|style="background:#DCDCDC;" align="center" + |'''Anti-hormonal agents'''
|
* [[Tamoxifen]] ([[Soltamox]], [[Nolvadex]])
* [[Prostaglandin]] inhibitors
|-
|style="background:#DCDCDC;" align="center" + |'''Tyrosine kinase inhibitors'''
(Novel [[molecular]] targeted therapies)
|
* [[Sorafenib]]
* [[Imatinib]] ([[Gleevec]])
|}
 
{|
|
[[File:Desmoid nsaid regression.png|thumb|600px|none|Desmoid tumour before (A, C) and 2 years after (B, D) the commencement of NSAID. Multi planner reformation (MPR)-CT demonstrates the sporadic desmoid tumours originating from the intra-abdominal cavity (arrows). Frontal (A, B) and axial (C, D) images are shown. The tumour has shown a remarkable shrinkage with a regression rate of 68.5% along with disappearance of intratumoural septa.[https://openi.nlm.nih.gov/detailedresult?img=PMC2270274_1477-7819-6-17-1&query=desmoid%20tumor&it=xg&req=4&npos=13 Source: Tanaka K. et al, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan]]]
|}


==Radiation Therapy==
==Radiation Therapy==
Rarely, [[radiation therapy]] is used if medical therapy and [[surgery]] fail.  Depending on the size and location of the [[tumor]], [[radiation]] is delivered either in low doses over the course of 5 to 6 weeks or in a single high dose. [[Radiation]] therapy is effective in approximately 30% of cases.
*[[Desmoid tumor|Desmoids]] are radiosensitive [[tumors]]
 
*[[Radiation therapy]] uses high-energy [[waves]] such as [[X-rays]] to kill or shrink [[Tumor cell|tumor cells]]
 
*Rarely, [[radiation therapy]] is used if:
 
**[[Patient]] is [[symptomatic]]
 
**[[Medical therapy template|Medical therapy]] fails
 
**[[Surgery]] fails
**[[Patient]] is not a good surgical candidate
**[[Patient]] declines [[surgery]]
**Surgical [[morbidity]] would be excessive
**Margins are positive post-[[resection]]
**[[Tumor]] [[Recurrence plot|recurrence]] post-[[resection]]
*Depending on individual [[patient]] characteristics, the [[Radiation therapy|radiation]] may be applied by following two methods:
**Conventional linear accelerators ([[radiotherapy]] treatment machines)
**[[Proton]] beam [[therapy]]
*Depending on the size and location of the [[tumor]], [[radiation]] is delivered either in low doses over the course of 5 to 6 weeks or in a single [[High doses of ionizing radiation|high dose]]
*[[Radiation]] therapy is effective in approximately 30% of cases
*Following complications can occur from [[radiation therapy]] due to late [[radiation]] effects:
**Secondary [[malignancies]] (especially in younger patients)
**[[Fibrosis]] associated with [[radiation therapy]]


==Tumor ablation==
*In some rare cases, [[ablation]] of [[Desmoid tumor|desmoid tumors]] can be used as a [[therapeutic]] option
*Following different kinds of [[ablation]] can be used:
**[[Cold]] [[ablation]]
**[[Heat]]/[[thermal ablation]]
**[[Microwave]] [[ablation]]
**High-frequency [[ultrasound]] [[ablation]]


==Reference==
==Reference==
Line 27: Line 96:
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]

Latest revision as of 03:38, 25 March 2019

Desmoid tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Desmoid tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

Wait and watch strategy is applied to desmoid tumors which are asymptomatic, unresectable, non-life threatening, not causing any significant impairment, and resectable tumors with increased morbidity associated with surgery.Different drugs including chemotherapeutic agents, NSAIDs, anti-hormonal agents and tyrosine kinase inhibitors can be used to shrink or stabilize the tumor size and to improve the symptoms. Radiation therapy and tumor ablation with heat, cold, microwave and/or high-frequency ultrasound waves can also be of therapeutic use as required.

Medical Therapy

Different drugs used in medical therapy of desmoid tumors
Drug class Drug name
Chemotherapeutic agents
NSAIDs
Anti-hormonal agents
Tyrosine kinase inhibitors

(Novel molecular targeted therapies)

Desmoid tumour before (A, C) and 2 years after (B, D) the commencement of NSAID. Multi planner reformation (MPR)-CT demonstrates the sporadic desmoid tumours originating from the intra-abdominal cavity (arrows). Frontal (A, B) and axial (C, D) images are shown. The tumour has shown a remarkable shrinkage with a regression rate of 68.5% along with disappearance of intratumoural septa.Source: Tanaka K. et al, Department of Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

Radiation Therapy

Tumor ablation

Reference

  1. Wilkinson MJ, Fitzgerald JE, Thomas JM, Hayes AJ, Strauss DC (2012). "Surgical resection for non-familial adenomatous polyposis-related intra-abdominal fibromatosis". BJS. 99 (5): 706–13. doi:10.1002/bjs.8703. PMID 22359346.
  2. Rammohan A, Wood JJ (2012). "Desmoid tumour of the breast as a manifestation of Gardner's syndrome". Int J Surg Case Rep. 3 (5): 139–42. doi:10.1016/j.ijscr.2012.01.004. PMC 3312056. PMID 22370045.

Template:WikiDoc Sources